Irritable Bowel Syndrome

  • Michael Camilleri


Irritable bowel syndrome (IBS) is a common and important disorder. This chapter focuses on the definitions, epidemiology, natural history and pathophysiology of IBS, as these are essential to understand strategies for optimal management and a discussion of conventional and newer treatments of IBS.


Irritable Bowel Syndrome Colonic Transit Irritable Bowel Syndrome Symptom Functional Constipation Functional Gastrointestinal Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE. Rome II: A multinational consensus document on functional gastrointestinal disorders. Gut, 45 (1999) 1–81.CrossRefGoogle Scholar
  2. 2.
    Kruis W, Thieme C, Weinzierl M, Schussler P, Holl J, Paulus W. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology, 87 (1984) 1–7.PubMedGoogle Scholar
  3. 3.
    Vanner SJ, Depew WT, Paterson WG, DaCosta LR, Groll AG, Simon JB, Djurfeldt M. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am. J. Gastroenterol., 94 (1999) 1912–1917.CrossRefGoogle Scholar
  4. 4.
    Manning AP, Thompson WG, Heaton KW, Morris AF. Towards a positive diagnosis of the irritable bowel. BMJ, 2 (1978) 653–654.PubMedCrossRefGoogle Scholar
  5. 5.
    Camilleri M, Choi MG. Review article: irritable bowel syndrome. Aliment. Pharmacol. Ther., 11 (1997) 3–15.PubMedCrossRefGoogle Scholar
  6. 6.
    Drossman DA, Whitehead WE, Camilleri M. Irritable Bowel Syndrome: A technical review for practice guideline development. Gastroenterology, 112 (1997) 2120–2137.PubMedCrossRefGoogle Scholar
  7. 7.
    Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Dig. Dis. Sci., 38 (1993) 1569–1580.PubMedCrossRefGoogle Scholar
  8. 8.
    Talley NJ, Zinsmeister AR, Melton LJ. Irritable bowel syndrome in a community: symptom subgroups, risk factors and health care utilization. Am. J. Epidemiol., 142 (1995) 76–83.PubMedGoogle Scholar
  9. 9.
    Camilleri M, Williams DE. Economic burden of irritable bowel syndrome reappraised with strategies to control expenditures. Pharmacoeconomics, 4 (2000) 331–338.CrossRefGoogle Scholar
  10. 10.
    Longstreth GF. Irritable bowel syndrome. Diagnosis in the managed care era. Dig. Dis. Sci., 42 (1997) 1105–1111.PubMedCrossRefGoogle Scholar
  11. 11.
    Bazzocchi G, Ellis J, Villaneuva-Meyer J, et al. Postprandial colonic transit and motor activity in chronic constipation. Gastroenterology, 98 (1990) 686–693.PubMedGoogle Scholar
  12. 12.
    Cann PA, Read NW, Brown C, Hobson N, Holdsworth CD. Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut, 24 (1983) 405–411.PubMedCrossRefGoogle Scholar
  13. 13.
    Vassallo M, Camilleri M, Phillips SF, Brown ML, Chapman NJ, Thomforde GM. Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology, 102 (1992) 102–108.PubMedGoogle Scholar
  14. 14.
    Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable bowel syndrome. Gut, 14 (1973) 125–132.PubMedCrossRefGoogle Scholar
  15. 15.
    Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut, 33 (1992) 825–830.PubMedCrossRefGoogle Scholar
  16. 16.
    Young SJ, Alpers DH, Norland CC, Woodruff RA Jr. Psychiatric illness and the irritable bowel syndrome. Practical implications for the primary physician. Gastroenterology, 70 (1976) 162–166.Google Scholar
  17. 17.
    Alpers DH. Editorial: why should psychotherapy be a useful approach to management of patients with non-ulcer dyspepsia? Gastroenterology, 119 (2000) 869–871.PubMedCrossRefGoogle Scholar
  18. 18.
    Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut, 44 (1999) 400 X06.Google Scholar
  19. 19.
    Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut, 47 (2000) 804–811.PubMedCrossRefGoogle Scholar
  20. 20.
    Haderstorfer B, Psycholgin D, Whitehead WE, Schuster MM. Intestinal gas production from bacterial fermentation of undigested carbohydrate in irritable bowel syndrome. Am. J. Gastroenterol., 84 (1989) 375–378.PubMedGoogle Scholar
  21. 21.
    Serra J, Azpiroz F, Malagelada J-R. Intestinal gas dynamics and tolerance in humans. Gastroenterology, 115 (1998) 542–550.PubMedCrossRefGoogle Scholar
  22. 22.
    Serra J, Azpiroz F, Malagelada J-R. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut, 48 (2001) 14–19.PubMedCrossRefGoogle Scholar
  23. 23.
    Drossman DA. Diagnosing and treating patients with refractory functional gastrointestinal disorders. Ann. Intern. Med., 123 (1995) 688–697.PubMedGoogle Scholar
  24. 24.
    Camilleri M, Thompson WG, Fleshman JW, Pemberton JH. Clinical management of intractable constipation. Ann. Intern. Med., 121 (1994) 520–528.PubMedGoogle Scholar
  25. 25.
    Clouse RE, Lustman PJ, Geisman RA, Alpers DH. Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience. Aliment. Pharmacol. Ther., 8 (1994) 409–416.PubMedCrossRefGoogle Scholar
  26. 26.
    Cann PA, Read NW, Holdsworth CD. What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut, 25 (1984) 168–173.PubMedCrossRefGoogle Scholar
  27. 27.
    Voderholzer WA, Schatke W, Muhldorfer BE, Klauser AG, Birkner B, Muller-Lissner SA. Clinical response to dietary fiber treatment of chronic constipation. Am. J. Gastroenterol., 92 (1997) 95–98.PubMedGoogle Scholar
  28. 28.
    Francis CY, Whorwell PJ. Bran and irritable bowel syndrome: time for reappraisal. Lancet, 344 (1994) 39–40.PubMedCrossRefGoogle Scholar
  29. 29.
    Cann PA, Read NW, Holdsworth CD, Barends D. Role of loperamide and placebo in management of irritable bowel syndrome. Dig. Dis. Sci., 29 (1984) 239–247.PubMedCrossRefGoogle Scholar
  30. 30.
    Efskind PS, Bernklev T, Vatn MH. A double-blind, placebo-controlled trial with loperamide in irritable bowel syndrome. Scand. J. Gastroenterol., 31 (1996) 463–468.PubMedCrossRefGoogle Scholar
  31. 31.
    Greenbaum DS, Mayle JE, Vanegeren LE, et al. The effects of desipramine on IBS compared with atropine and placebo. Dig. Dis. Sci., 32 (1987) 257–266.PubMedCrossRefGoogle Scholar
  32. 32.
    Ritchie JA, Truelove SC. Comparison of various treatments for irritable bowel syndrome. BMJ, 281 (1980) 1317–1319.PubMedCrossRefGoogle Scholar
  33. 33.
    Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials. Am. J. Gastroenterol., 91 (1996) 277–283.PubMedGoogle Scholar
  34. 34.
    Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of the irritable bowel syndrome with Chinese herbal medicine: a randomised controlled trial. JAMA, 280 (1998) 1585–1589.PubMedCrossRefGoogle Scholar
  35. 35.
    Camilleri, M, Northcutt, AR, Kong, S, et al. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet, 355 (2000) 1035.Google Scholar
  36. 36.
    Jones, RH, Holtmann, G, Rodrigo, L, et al. Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients. Aliment. Pharmacol. Ther., 13 (1999) 1419–1427.PubMedCrossRefGoogle Scholar
  37. 37.
    Camilleri M, Prather CM. The irritable bowel syndrome: mechanisms and a practical approach to management. Ann. Intern. Med., 116 (1992) 1001–1008.PubMedGoogle Scholar
  38. 38.
    Camilleri M. Management of the irritable bowel syndrome. Gastroenterology, 129 (2001) 652–668.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2003

Authors and Affiliations

  • Michael Camilleri

There are no affiliations available

Personalised recommendations